NanoSilican Advanced Materials Shares Middle East Results at Korea Forum
NANOSILICAN Advanced Materials shared its Middle East pharmaceutical anti-counterfeiting results at the 22nd Korea–Middle East Cooperation Forum in Seoul on the 20th, and its partner GEG Group said the technology has saved more than $100 million in government funds since 2022, (주) 서울경제티브이 reported.
For Nanosilican Advanced Materials — a functional nano-materials company formerly known as Nanobrick — the forum was a showcase for a partnership that has run since 2019 and, the company says, is now ready to expand toward Africa.
GEG Group chief details the savings
Amer Barzani, representative of the multinational investment firm GEG Group, appeared as a speaker and presented the results of local projects launched through the partnership with Nanosilican Advanced Materials, according to (주) 서울경제티브이.
“Advanced nano-magnetic-based technology and security solutions played a key role in improving institutions in the Middle East’s health sector and in rooting out the distribution of illegal and counterfeit medicines,” Barzani said. “We were able to substantively support improvements in the local medical environment and health-sector reforms.”
The savings figure is the centerpiece of his presentation. Barzani said that since the technology was applied and put into operation in 2022, the government-level reduction in spending has exceeded $100 million — about 133 billion won (주) 서울경제티브이 reported. He said those freed-up funds connected directly to easing the economic burden on ordinary citizens and consumers who buy medicines.
“Based on the long-term partnership with Nanosilican Advanced Materials that has continued since 2019, we were able to achieve tangible results,” he said.
Why counterfeit medicine enforcement matters
The Korea-Arab Society, established in 2008 as a private-government joint body to promote exchange between Korea and the 22 Arab states, has positioned the forum as a venue where Korean companies can present projects. The company’s own account of the results, released on the day of the forum, frames the outcome as institutional as much as commercial: the security solutions supported health-sector reform, not only product protection.
A $1.05 million supply contract, disclosed
One day before the forum, the company disclosed a new contract. On the 19th, Nanosilican Advanced Materials signed a supply agreement worth $1.05 million — about 1.4 billion won — for anti-counterfeiting security products with a supplier of pharmaceutical security solutions to a Middle East government, (주) 서울경제티브이 reported.
The contract signals continuity: the same technology credited with the government savings is still being procured by the region’s public health authorities.
Choi Jong-wook points the business toward Africa
Choi Jong-wook, representative director of Nanosilican Advanced Materials, spoke in the afternoon session and laid out the expansion plan.
“Building on the Middle East market, which has entered a stabilization phase, we will broaden our footprint into the African market and seek to grow revenue on the basis of our original security technology,” Choi said.
A company official echoed that direction. “The forum shared the fruits of a collaboration that has contributed to drug safety and health reform on the ground in the Middle East,” the official said. “We will create a growth engine by combining stable operation of the Middle East market, opening of the African market, and the competitiveness of our security technology.”
From Nanobrick to Nanosilican
The company listed on the KOSDAQ market in 2019 under its former name, Nanobrick. In January 2025 it was acquired by Dream Castle and adopted its current name, Nanosilican Advanced Materials.
The open question
The company has not disclosed which Middle East government the new $1.05 million contract serves, nor which countries in Africa it will enter first.